Literature DB >> 25749846

Treatment of Menière's Disease.

Jeffrey D Sharon1, Carolina Trevino, Michael C Schubert, John P Carey.   

Abstract

OPINION STATEMENT: Diagnosis of Menière's disease is made with a characteristic patient history, including discrete episodes of vertigo lasting 20 min or longer, accompanied by sensorineural hearing loss, which is typically low frequency at first, aural fullness, and tinnitus. Workup includes audiometry, a contrast enhanced MRI of the internal auditory canals, and exclusion of other diseases that can produce similar symptoms, like otosyphilis, autoimmune inner ear disease, perilymphatic fistula, superior semicircular canal syndrome, Lyme disease, multiple sclerosis, vestibular paroxysmia, and temporal bone tumors. A history of migraine should be sought as well because of a high rate of co-occurrence (Rauch, Otolaryngol Clin North Am 43:1011-1017, 2010). Treatment begins with conservative measures, including low salt diet, avoidance of stress and caffeine, and sleep hygiene. Medical therapy with a diuretic is the usual next step. If that fails to control symptoms, then the options of intratympanic (IT) steroids and betahistine are discussed. Next tier treatments include the Meniett device and endolymphatic sac surgery, but the efficacy of both is controversial. If the above measures fail to provide symptomatic control of vertigo, then ablative therapies like intratympanic gentamicin are considered. Rarely, vestibular nerve section or labyrinthectomy is considered for a patient with severe symptoms who does not show a reduction in vestibular function with gentamicin. Benzodiazepines and anti-emetics are used for symptomatic control during vertigo episodes. Rehabilitative options for unilateral vestibular weakness include physical therapy and for unilateral hearing loss include conventional hearing aids, contralateral routing of sound (CROS) and osseointegrated hearing aids.

Entities:  

Year:  2015        PMID: 25749846     DOI: 10.1007/s11940-015-0341-x

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  64 in total

1.  Combined retrosigmoid retrolabyrinthine vestibular nerve section: results of our experience over 10 years.

Authors:  Nebil Goksu; Metin Yilmaz; Ismet Bayramoglu; Yildirim A Bayazit
Journal:  Otol Neurotol       Date:  2005-05       Impact factor: 2.311

Review 2.  Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.

Authors:  Michelle N McDonnell; Susan L Hillier
Journal:  Cochrane Database Syst Rev       Date:  2015-01-13

3.  Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.

Authors:  Marco Antonio Garduño-Anaya; Heloísa Couthino De Toledo; Ramón Hinojosa-González; Carlo Pane-Pianese; Luis Camilo Ríos-Castañeda
Journal:  Otolaryngol Head Neck Surg       Date:  2005-08       Impact factor: 3.497

4.  Long-term effects of Ménière's disease on hearing and quality of life.

Authors:  S E Kinney; S A Sandridge; C W Newman
Journal:  Am J Otol       Date:  1997-01

5.  Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.

Authors:  L B Minor
Journal:  Am J Otol       Date:  1999-03

6.  Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.

Authors:  Iee Ching Wu; Lloyd B Minor
Journal:  Laryngoscope       Date:  2003-05       Impact factor: 3.325

7.  Use of a diuretic (Dyazide) in the treatment of Menière's disease. A double-blind cross-over placebo-controlled study.

Authors:  G W van Deelen; E H Huizing
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1986       Impact factor: 1.538

8.  Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial.

Authors:  Robert Stokroos; Herman Kingma
Journal:  Acta Otolaryngol       Date:  2004-03       Impact factor: 1.494

9.  Ménière's disease in children.

Authors:  W L Meyerhoff; M M Paparella; D Shea
Journal:  Laryngoscope       Date:  1978-09       Impact factor: 3.325

10.  Cochlear implantation in patients with bilateral Ménière's syndrome.

Authors:  Lawrence R Lustig; Jennifer Yeagle; John K Niparko; Lloyd B Minor
Journal:  Otol Neurotol       Date:  2003-05       Impact factor: 2.311

View more
  12 in total

1.  The Clinical Benefit of Device Therapy for Meniere's Disease in Adults: Systematic Review and Meta-Analysis.

Authors:  Shu Jia Wang; Hong Yang; Yang-Yang Yao; Hui-Yun Gu; Lu-Lu Lin; Chao Zhang; Jie Luo
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

2.  Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.

Authors:  Bryan Ward; Vincent Wettstein; John Golding; Giulia Corallo; Daniele Nuti; Franco Trabalzini; Marco Mandala
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

3.  Intratympanic (IT) Therapies for Menière's Disease: Some Consensus Among the Confusion.

Authors:  Desi P Schoo; Grace X Tan; Matthew R Ehrenburg; Seth E Pross; Bryan K Ward; John P Carey
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-05-03

4.  Low-salt diet increases mRNA expression of aldosterone-regulated transporters in the intermediate portion of the endolymphatic sac.

Authors:  Ai Matsubara; Takenori Miyashita; Kentaro Nakashima; Nozomu Mori; Si-Young Song; Hiroshi Hoshikawa
Journal:  Pflugers Arch       Date:  2022-02-03       Impact factor: 3.657

Review 5.  Neuro-otology- some recent clinical advances.

Authors:  Miriam S Welgampola; Gülden Akdal; G Michael Halmagyi
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

6.  Neurovestibular Compensation following Ototoxic Lesion and Labyrinthectomy.

Authors:  Hamed Yazdanshenas; Anousheh Ashouri; Galen Kaufman
Journal:  Int Arch Otorhinolaryngol       Date:  2016-03-10

Review 7.  Acupuncture Points Stimulation for Meniere's Disease/Syndrome: A Promising Therapeutic Approach.

Authors:  Jiaojun He; Liyuan Jiang; Tianqiang Peng; Meixia Xia; Huade Chen
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-28       Impact factor: 2.629

8.  Association of Coffee Consumption with Hearing and Tinnitus Based on a National Population-Based Survey.

Authors:  Sang-Youp Lee; Gucheol Jung; Myoung-Jin Jang; Myung-Whan Suh; Jun Ho Lee; Seung Ha Oh; Moo Kyun Park
Journal:  Nutrients       Date:  2018-10-04       Impact factor: 5.717

9.  Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease.

Authors:  Mehrdad Rogha; Hamidreza Abtahi; Leila Asadpour; Hossein Ghazavi; Reza Pourmohammadi; Masoud Maleki; Keyvan Ghadimi
Journal:  Iran J Otorhinolaryngol       Date:  2019-07

10.  Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).

Authors:  Christine Adrion; Carolin Simone Fischer; Judith Wagner; Robert Gürkov; Ulrich Mansmann; Michael Strupp
Journal:  BMJ       Date:  2016-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.